InsiderClue
Insiders · Profile

KEATING LAURIE

Director at Immuneering · Director at PepGen · EVP, Chief Legal Officer at ALNYLAM PHARMACEUTICALS. Filing since 30 May 2017. CIK 0001620743

IMRX Immuneering Corp Director · 2 trades PEPG PepGen Inc. Director · 1 trade ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Legal Officer · 18 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IMRX Immuneering Corp
16 May 2022
Director
Bought
7,000
$35.00K
100%
PEPG PepGen Inc.
6 May 2022
Director
Bought
4,166
$49.99K
opened
ALNY ALNYLAM PHARMACEUTICALS, INC.
5 Aug 2021
EVP, Chief Legal Officer
Sold, plan not stated
10,000
$1.89M
66.1%
IMRX Immuneering Corp
3 Aug 2021
Director
Bought
7,000
$105.00K
opened
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Jul 2021
EVP, Chief Legal Officer
Sold, plan not stated
6,812
$1.22M
57.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
9 Jun 2021
EVP, Chief Legal Officer
Sold, plan not stated
1,734
$267.04K
25.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Jan 2021
EVP, Chief Legal Officer
Sold, plan not stated
9,027
$1.53M
80.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Jan 2021
EVP, Chief Legal Officer
Sold, plan not stated
14,941
$2.39M
87.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Jan 2021
EVP, Chief Legal Officer
Sold, plan not stated
758
$116.73K
25.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Jul 2020
EVP, Chief Legal Officer
Sold, plan not stated
47,250
$7.59M
94.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Apr 2020
EVP, Chief Legal Officer
Sold, plan not stated
10,000
$1.39M
40.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Feb 2020
EVP, Chief Legal Officer
Sold, plan not stated
10,000
$1.29M
44.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
29 Jan 2020
EVP, Chief Legal Officer
Sold, plan not stated
6,337
$754.10K
42.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Jan 2020
EVP, Chief Legal Officer
Sold, plan not stated
41,037
$4.83M
82.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Jun 2018
SVP, GC & Secretary
Sold, plan not stated
1,563
$164.18K
9.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Mar 2018
SVP, GC & Secretary
Sold, plan not stated
1,562
$234.03K
9.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Mar 2018
SVP, GC & Secretary
Sold, plan not stated
10,000
$1.50M
40.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Mar 2018
SVP, GC & Secretary
Sold, plan not stated
10,000
$1.40M
40.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Dec 2017
SVP, GC & Secretary
Sold, plan not stated
6,249
$757.40K
35.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
1 Dec 2017
SVP, GC and Secretary
Sold, plan not stated
30,000
$4.08M
72.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
30 May 2017
SVP, GC and Secretary
Bought
11,500
$751.50K
opened
21 decisions on file.